Farther Finance Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$774K Buy
8,716
+2,723
+45% +$258K 0.01% 1293
2026
Q2
$531K Sell
5,993
-544
-8% -$47.7K ﹤0.01% 1522
2026
Q1
$595K Sell
6,537
-3,583
-35% -$329K 0.01% 1279
2025
Q4
$910K Buy
10,120
+933
+10% +$88.5K 0.01% 935
2025
Q3
$905K Buy
9,187
+42
+0.5% +$4.16K 0.01% 769
2025
Q2
$834K Buy
9,145
+1,845
+25% +$178K 0.02% 679
2025
Q1
$820K Buy
7,300
+1,849
+34% +$198K 0.02% 590
2024
Q4
$576K Sell
5,451
-374
-6% -$40.1K 0.02% 535
2024
Q3
$629K Buy
5,825
+587
+11% +$64.1K 0.02% 508
2024
Q2
$555K Buy
5,238
+4,807
+1,115% +$567K 0.03% 447
2024
Q1
$55.9K Sell
431
-95
-18% -$11.9K ﹤0.01% 1145
2023
Q4
$64.1K Buy
526
+156
+42% +$17.4K ﹤0.01% 950
2023
Q3
$41.5K Buy
370
+19
+5% +$2.41K 0.01% 829
2023
Q2
$51.1K Buy
351
+141
+67% +$19.2K 0.01% 665
2023
Q1
$27.1K Buy
210
+29
+16% +$3.64K 0.01% 805
2022
Q4
$23.1K Buy
+181
New +$21K 0.01% 689

Other funds holding ZBH

Farther Finance Advisors's ZBH Position: Q3 2026 in Review

Farther Finance Advisors increased its Zimmer Biomet (ZBH) stake by 45% in Q3 2026, buying an estimated $258K and bringing the position to 8,716 shares worth $774K. The position accounts for 0.01% of the portfolio, ranked #1293.

Farther Finance Advisors first reported a position in ZBH in Q4 2022 and has held it in 16 quarters since. The position peaked at $910K in Q4 2025. 28 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Farther Finance Advisors held 8,716 shares of Zimmer Biomet worth $774K as of Q3 2026.
  • Farther Finance Advisors bought 2,723 Zimmer Biomet shares in Q3 2026, an estimated $258K.
  • Zimmer Biomet made up 0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1293 holding.
  • Farther Finance Advisors first reported a position in Zimmer Biomet in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Zimmer Biomet position peaked at $910K in Q4 2025.
  • 28 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.